Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DNA TWOPOINTO INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-05-14 to 2026-05-13
Current total value of award: $225000
Description: YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY